Guy Krippner
Director/Board Member at Cardiora Pty Ltd.
Profile
Dr. Guy Krippner obtained his PhD from the University of Adelaide and completed post-doctoral research fellowships at both Oxford University and the University of Sydney.
Dr. Guy Krippner has had 16 years of experience in synthetic organic chemistry including 12 years as a senior Medicinal Chemist.
Previously, Dr. Guy Krippner was Head of Chemistry at Starpharma where he led a team of skilled synthetic and analytical chemists who collaborated with both commercial and academic partners to develop dendrimer based drug candidates for a variety of biological targets.
He has co-authored over 18 publications and is a co-inventor of 10 filed patents.
Guy Krippner active positions
| Companies | Position | Start |
|---|---|---|
Cardiora Pty Ltd.
 Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Former positions of Guy Krippner
| Companies | Position | End |
|---|---|---|
Verva Pharmaceuticals Ltd.
 Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Verva Pharmaceuticals Ltd. developed therapies to treat diabetes. Its products include insulin sensitizers, insulin secretagogues, fat formation inhibitors for the prevention, treament of obesity, drug-induced weight gain and insulin secretion modulators. The company was founded in 1996 and was headquartered in Geelong, Australia. | Corporate Officer/Principal | - |
Training of Guy Krippner
| University of Adelaide | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Verva Pharmaceuticals Ltd.
Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Verva Pharmaceuticals Ltd. developed therapies to treat diabetes. Its products include insulin sensitizers, insulin secretagogues, fat formation inhibitors for the prevention, treament of obesity, drug-induced weight gain and insulin secretion modulators. The company was founded in 1996 and was headquartered in Geelong, Australia. | Health Technology |
Cardiora Pty Ltd.
Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia. | Miscellaneous |
- Stock Market
- Insiders
- Guy Krippner